Hologic, Inc. provided revenue guidance for the first quarter of 2024. For the year, the company expects Total revenue of $1,013.1 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
75.58 USD | +0.58% | -0.53% | +5.71% |
05-09 | Argus Adjusts Price Target on Hologic to $95 From $89 | MT |
05-06 | Lumos Diagnostics Concludes Initial Phase of Development Deal with Hologic for Fetal Fibronectin Test; Shares Jump 6% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.71% | 17.54B | |
+11.05% | 226B | |
+9.13% | 188B | |
+13.05% | 137B | |
+25.84% | 108B | |
+0.34% | 63.19B | |
+11.66% | 52.26B | |
+5.62% | 51B | |
+6.22% | 43.89B | |
+5.07% | 38.07B |
- Stock Market
- Equities
- HOLX Stock
- News Hologic, Inc.
- Hologic, Inc. Provides Revenue Guidance for the First Quarter of 2024